Why glycine transporters have different stoichiometries - ScienceDirect
PDF) A comparison of the transport kinetics of glycine transporter 1 and glycine transporter 2
The glycine transport inhibitor sarcosine is an NMDA receptor co‐agonist that differs from glycine - Zhang - 2009 - The Journal of Physiology - Wiley Online Library
Differential distribution of glycine transporters in Müller cells and neurons in amphibian retinas | Visual Neuroscience | Cambridge Core
Inhibition of System A-mediated glycine transport in cortical synaptosomes by therapeutic concentrations of clozapine: implications for mechanisms of action | Molecular Psychiatry
Calcium- and Syntaxin 1-mediated Trafficking of the Neuronal Glycine Transporter GLYT2* - Journal of Biological Chemistry
MS Binding Assays for Glycine Transporter 2 (GlyT2) Employing Org25543 as Reporter Ligand - Ackermann - 2021 - ChemMedChem - Wiley Online Library
IJMS | Free Full-Text | Analysis of Binding Determinants for Different Classes of Competitive and Noncompetitive Inhibitors of Glycine Transporters
The Second Intracellular Loop of the Glycine Transporter 2 Contains Crucial Residues for Glycine Transport and Phorbol Ester-induced Regulation - ScienceDirect
Neurobiology of glycine transporters: From molecules to behavior - ScienceDirect
The glycine transport inhibitor sarcosine is an NMDA receptor co‐agonist that differs from glycine - Zhang - 2009 - The Journal of Physiology - Wiley Online Library
The Zebrafish shocked Gene Encodes a Glycine Transporter and Is Essential for the Function of Early Neural Circuits in the CNS | Journal of Neuroscience
Molecular Basis for Substrate Discrimination by Glycine Transporters*
Glycine supply to human enterocytes mediated by high-affinity basolateral GLYT1 - ScienceDirect
Structure, function and regulation of glycine neurotransporters - ScienceDirect
The glycine transport inhibitor sarcosine is an NMDA receptor co‐agonist that differs from glycine - Zhang - 2009 - The Journal of Physiology - Wiley Online Library
Glycine transporter 1 as a potential therapeutic target for schizophrenia-related symptoms: Evidence from genetically modified mouse models and pharmacological inhibition - ScienceDirect
